The Abbott Laboratories line shows up 138 times in the congressional disclosure record between 2012 and 2026, filed by 49 members: 76 purchases against 61 sales. On balance the chamber has been net buyers, and the purchases sit down 1.2% against the latest close.
*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.
Reported a ABT purchase in filings from the last 90 days, newest first. 2 members.
Members ranked by how their reported ABT purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2017-07-05 | Rohit Khanna | BUY | $1K–$15K | $49.00 | $108.33 2026-09-04 | +121.1% |
| 2017-04-19 | K. Michael Conaway | SELL | $15K–$50K | $43.59 | $108.33 2026-09-04 | -148.5% exit |
| 2017-02-23 | Sheldon Whitehouse | SELL | $1K–$15K | $45.40 | $104.88 2026-10-26 | -131.0% exit |
| 2017-01-26 | James B. Renacci | BUY | $1K–$15K | $40.96 | $108.33 2026-09-04 | +164.5% |
| 2017-01-26 | Peter Welch | BUY | $1K–$15K | $40.96 | $104.88 2026-10-26 | +156.1% |
| 2016-12-20 | James B. Renacci | SELL | $1K–$15K | $38.19 | $108.33 2026-09-04 | -183.7% exit |
| 2016-12-20 | James B. Renacci | BUY | $1K–$15K | $38.19 | $108.33 2026-09-04 | +183.7% |
| 2016-11-15 | Sheldon Whitehouse | BUY | $1K–$15K | $39.81 | $108.33 2026-09-04 | +172.1% |
| 2016-11-10 | Virginia Foxx | SELL | $1K–$15K | $40.61 | $108.33 2026-09-04 | -166.8% exit |
| 2016-06-01 | Debbie Dingell | BUY | $1K–$15K | $39.50 | $108.33 2026-09-04 | +174.3% |
| 2016-04-23 | Mike Kelly | BUY | $1K–$15K | $44.08 | $108.33 2026-09-04 | +145.8% |
| 2016-04-19 | Shelley M Capito | BUY | $1K–$15K | $43.85 | $108.33 2026-09-04 | +147.1% |
| 2016-03-31 | William Cassidy | BUY | $1K–$15K | $41.83 | $108.33 2026-09-04 | +159.0% |
| 2016-03-31 | William Cassidy | BUY | $1K–$15K | $41.83 | $108.33 2026-09-04 | +159.0% |
| 2016-01-28 | Virginia Foxx | BUY | $1K–$15K | $36.71 | $108.33 2026-09-04 | +195.1% |
| 2016-01-22 | Virginia Foxx | BUY | $1K–$15K | $40.03 | $108.33 2026-09-04 | +170.6% |
| 2015-09-23 | James B. Renacci | BUY | $1K–$15K | $42.20 | $104.88 2026-10-26 | +148.5% |
| 2015-09-23 | Robert J. Wittman | SELL | $1K–$15K | $42.20 | $104.88 2026-10-26 | -148.5% exit |
| 2015-08-21 | Virginia Foxx | SELL | $15K–$50K | $47.13 | $104.88 2026-10-26 | -122.5% exit |
| 2015-07-30 | Frank A. LoBiondo | BUY | $1K–$15K | $50.77 | $104.88 2026-10-26 | +106.6% |
| 2015-07-28 | Diane Black | BUY | $1K–$15K | $50.94 | $104.88 2026-10-26 | +105.9% |
| 2015-07-21 | Shelley M Capito | BUY | $1K–$15K | $49.76 | $104.88 2026-10-26 | +110.8% |
| 2015-07-09 | James M Inhofe | SELL | $50K–$100K | $49.19 | $104.88 2026-10-26 | -113.2% exit |
| 2015-05-27 | Lois Frankel | SELL | $1K–$15K | $49.01 | $104.88 2026-10-26 | -114.0% exit |
| 2015-05-15 | RICHARD M BURR | SELL | $1K–$15K | $48.71 | $104.88 2026-10-26 | -115.3% exit |
| 2015-05-15 | RICHARD M BURR | BUY | $1K–$15K | $48.71 | $104.88 2026-10-26 | +115.3% |
| 2015-04-06 | Michael T. McCaul | SELL | $50K–$100K | $46.30 | $104.88 2026-10-26 | -126.5% exit |
| 2015-04-06 | Michael T. McCaul | SELL | $100K–$250K | $46.30 | $104.88 2026-10-26 | -126.5% exit |
| 2015-03-25 | Michael T. McCaul | SELL | $15K–$50K | $46.53 | $104.88 2026-10-26 | -125.4% exit |
| 2015-03-25 | Michael T. McCaul | SELL | $15K–$50K | $46.53 | $104.88 2026-10-26 | -125.4% exit |
| 2015-03-18 | Virginia Foxx | BUY | $15K–$50K | $47.39 | $104.88 2026-10-26 | +121.3% |
| 2015-02-12 | Thomas R Carper | BUY | $1K–$15K | $45.22 | $104.88 2026-10-26 | +131.9% |
| 2014-05-11 | George Holding | BUY | $1K–$15K | $38.99 | $104.88 2026-10-26 | +169.0% |
| 2013-10-03 | RICHARD M BURR | BUY | $1K–$15K | $33.29 | $104.88 2026-10-26 | +215.1% |
| 2012-10-01 | JAMES M INHOFE | BUY | $1K–$15K | $33.14 | $104.88 2026-10-26 | +216.4% |
| 2012-10-01 | JAMES M INHOFE | SELL | $1K–$15K | $33.14 | $104.88 2026-10-26 | -216.4% exit |
| 2012-08-14 | James B. Renacci | SELL | $15K–$50K | $31.75 | $104.88 2026-10-26 | -230.3% exit |
| 2012-08-14 | James B. Renacci | BUY | $15K–$50K | $31.75 | $104.88 2026-10-26 | +230.3% |
Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.
49 members of the U.S. House and Senate have disclosed Abbott Laboratories transactions under the STOCK Act — 76 purchases and 61 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
2 members disclosed a ABT purchase in the last 90 days — most recently Gilbert Cisneros on 2026-09-18. See the "Lawmakers who bought ABT recently" section above for the dated list.
Notional-weighted, lawmakers' disclosed ABT buys are down 1.2% versus the latest close of $108.33. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ABT and how it performed.